| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697189 | Brachytherapy | 2017 | 22 Pages |
Abstract
We present concise outcomes of PC, DFS, OS, and toxicity for cervical cancer patients treated with chemoradiation and HDR BT. Our data suggest an improvement in outcomes with the use of IBBT compared with traditional Point A dose prescriptions. In conclusion, HDR BT is a safe, effective modality when combined with IBBT.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jyoti Mayadev, Akila Viswanathan, Yu Liu, Chin-Shang Li, Kevin Albuquerque, Antonio L. Damato, Sushil Beriwal, Beth Erickson,